CIK 0001521036
- Large accelerated filer
Lantheus Holdings, Inc.
Sign in to watch- Ticker
- LNTH
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 352318913
- Phone
- +1 978-671-8001
- Business address
- 201 BURLINGTON ROAD, SOUTH BUILDING, BEDFORD, MA, 01730
- Former names
- Lantheus MI Holdings, Inc.
- 4 Planned sale President sold 18,023 shares at $61.96 ($1,116,705)
- 4 Open-market buy 10% owner bought 60,431,039 shares at $0.95 ($57,409,487)
- 4 Shares withheld for taxes Chief Medical Officer gave up 546 shares (to pay taxes)
- 4 Planned sale Director sold 4,090 shares at an average $64.06 ($262,005)
- 4 Shares withheld for taxes CFO and Treasurer gave up 35,730 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Business Officer gave up 25,574 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 6,360 shares (to pay taxes)
- 4 Shares withheld for taxes President gave up 20,728 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 8,457 shares (to pay taxes)
- 4 Open-market sale Director sold 22,389 shares at an average $65.42 ($1,464,749)
- 4 Grant or award CFO and Treasurer acquired 66,309 shares (grant or award)
- 4 Planned sale Director sold 93,863 shares at an average $65.31 ($6,129,889)
- 4 Grant or award President acquired 53,457 shares (grant or award)
- 4 Grant or award Chief Business Officer acquired 52,971 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 18,564 shares (grant or award)
- 4 Grant or award See Remarks acquired 36,922 shares (grant or award)
- 4 Grant or award CEO acquired 131,496 shares (grant or award)
- 4 Grant or award Chief Accounting Officer acquired 11,502 shares (grant or award)
- 4 Planned sale Chief Accounting Officer sold 341 shares at $55.31 ($18,861)
- 3 Insider Initial Statement of Ownership
Page 7 of 30 · 598 filings